Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Programmed cell death in primary Sjögren’s disease: regulatory network analysis and therapeutic prospects evaluation

  • Wang Chengzhi1,2
  • Liu Yifan3
  • Li Songwei1,2
  • Du Mengmeng1,2
  • Zhu Keying1,2
  • Li Huan1,2
  1. 1Department of Rheumatology, The First Affiliated Hospital of Henan University of Chinese Medicine
  2. 2The First Clinical College of Henan University of Chinese Medicine
  3. 3The Second Affiliated Hospital of Henan University of Chinese Medicine
Open at sourceDOICite

Abstract

Primary Sjögren’s disease (SjD) is an autoimmune disorder characterized by chronic inflammation of exocrine glands, such as the salivary and lacrimal glands. The pathogenesis of SjD remains largely unclear, and there are currently no effective curative therapies. Programmed cell death (PCD) and its regulatory network play a crucial role in the onset and progression of SjD. PCD mechanisms such as apoptosis, autophagy, pyroptosis, and ferroptosis are widely involved in the pathological mechanisms and prognosis of SjD by regulating the immune-inflammatory microenvironment, mediating the imbalance of glandular epithelial cell homeostasis, and affecting the release and clearance of self-antigens. Based on this, targeting the regulation of PCD to treat SjD has become a new therapeutic strategy. Existing evidence indicates that modulating the expression of certain miRNAs and proteins, as well as employing modern medical drugs, traditional Chinese medicine, and their active components, can influence the pathological processes of glandular inflammation and tissue damage in SjD through the regulation of apoptosis, autophagy, pyroptosis, and ferroptosis. These findings provide potential targets for precise treatment based on the PCD network.This article reviews recent relevant literature to clarify the relationship between PCD and SjD, and focuses on the molecular regulatory networks of different types of PCD in SjD and their therapeutic prospects, aiming to provide new ideas and insights for the prevention and treatment of SjD.

Related

  1. Cold Tolerance in Alfalfa: Physiological Mechanisms, Regulatory Networks, and Molecular Breeding Prospects.
    Weiguang Yang, Xiaojia Shi, Jinyang Lu +1
    Plants (Basel, Switzerland)Peer-reviewedCC BYFull textPlant biologyEurope PMC
  2. Therapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model
    Francois Ricordeau, Sebastien Arthaud, Leila Langbour +6
    Annals of NeurologyPeer-reviewedCC BYFull textNeuroscienceEpidemiology & public healthHAL
  3. Mitochondria as immunometabolic hubs in psoriasis: pathogenic mechanisms and therapeutic prospects
    Fangru Zhao, Yaoxing Guo, Xin Tong +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefDOAJ
  4. Postharvest senescence of broccoli in the multi-omics era: molecular mechanisms, regulatory networks, and prospects for germplasm innovation
    Han-Min Jiang, Li-Li Liu, Zheng-Hua Wen +5
    Frontiers in Plant SciencePeer-reviewedCC BY 4.0Plant biologyFrontiersCrossref
  5. Natural Products for Pancreatitis: Recent Advances, Molecular Mechanisms and Therapeutic Prospects
    Shiyan Su, Jing Yang, Meiyue Zhu +5
    CellsPeer-reviewedCC BY 4.0Cell biologyCrossref

Cite

BibTeXRIS
BibTeX
@article{chengzhi2026programmed,
  title = {{Programmed cell death in primary Sjögren’s disease: regulatory network analysis and therapeutic prospects evaluation}},
  author = {Wang Chengzhi and Liu Yifan and Li Songwei and Du Mengmeng and Zhu Keying and Li Huan},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1937363},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1937363/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Programmed cell death in primary Sjögren’s disease: regulatory network analysis and therapeutic prospects evaluation
AU  - Wang Chengzhi
AU  - Liu Yifan
AU  - Li Songwei
AU  - Du Mengmeng
AU  - Zhu Keying
AU  - Li Huan
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1937363
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1937363/full
AB  - Primary Sjögren’s disease (SjD) is an autoimmune disorder characterized by chronic inflammation of exocrine glands, such as the salivary and lacrimal glands. The pathogenesis of SjD remains largely unclear, and there are currently no effective curative therapies. Programmed cell death (PCD) and its regulatory network play a crucial role in the onset and progression of SjD. PCD mechanisms such as apoptosis, autophagy, pyroptosis, and ferroptosis are widely involved in the pathological mechanisms and prognosis of SjD by regulating the immune-inflammatory microenvironment, mediating the imbalance of glandular epithelial cell homeostasis, and affecting the release and clearance of self-antigens. Based on this, targeting the regulation of PCD to treat SjD has become a new therapeutic strategy. Existing evidence indicates that modulating the expression of certain miRNAs and proteins, as well as employing modern medical drugs, traditional Chinese medicine, and their active components, can influence the pathological processes of glandular inflammation and tissue damage in SjD through the regulation of apoptosis, autophagy, pyroptosis, and ferroptosis. These findings provide potential targets for precise treatment based on the PCD network.This article reviews recent relevant literature to clarify the relationship between PCD and SjD, and focuses on the molecular regulatory networks of different types of PCD in SjD and their therapeutic prospects, aiming to provide new ideas and insights for the prevention and treatment of SjD.
SN  - 1664-3224
ER  -